Last reviewed · How we verify

NCT05296850

Immediate Effects of Kinesio Taping and Manual Release in Young Adults With Pes Planus

Status unknown NA Last updated 7 April 2022
What this trial tests

NA trial testing Manual Release in Pes Planus in 40 participants. Status unknown.

Timeline
16 February 2022
Primary endpoint
16 April 2022
16 April 2022

Quick facts

Lead sponsorAnkara Yildirim Beyazıt University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date16 February 2022
Primary completion16 April 2022
Estimated completion16 April 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Yildirim Beyazıt University

Who can join

Adults 18 to 25, any sex, with Pes Planus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pes planus is a postural deformity seen with decreased medial longitudinal arch (MLA) height and this causes intense stress on the plantar fascia. Pes planus may affect individuals' activities of daily living, their productivity in occupational environments, and the risk of injury and performance in sports; It has also been reported that it may cause different musculoskeletal diseases such as plantar fasciitis, medial tibial stress syndrome, patellofemoral disorders and back pain in the future. Many clinical methods are used as a treatment for pes planus and most treatments involve supporting an overstretched plantar fascia and weakened MLA. The aim of the study is to investigate the immediate effects of kinesio taping and manual release on lower extremity performance in young adults with pes planus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pes Planus

Currently open trials in the same condition.

Other Ankara Yildirim Beyazıt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05296850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing